Clinical Trial Update: Treatment of Egyptian Hepatitis C Genotype 4 Infected Children and Adolescents With Combined Ledipasvir/Sofosbuvir [Phase 4]

View source ↗

Summary

Phase 4 study evaluating ledipasvir/sofosbuvir in children and adolescents with Hepatitis C Genotype 4.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis C

Drugs mentioned

• Ledipasvir/sofosbuvir (Ledipasvir and sofosbuvir)

Snippet

Sponsor: Yassin Abdelghaffar Charity Center for Liver Disease and Research | Conditions: Hepatitis C Genotype 4 | Phase 4 | Status: UNKNOWN